Literature DB >> 1316283

Effects of 5-HT1A receptor agonists on the circadian rhythm of wheel-running activity in hamsters.

K Tominaga1, S Shibata, S Ueki, S Watanabe.   

Abstract

The effects of 5-HT1A receptor agonists 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), buspirone and ipsapirone on wheel-running activity in hamsters were investigated in comparison with those of GABAA receptor agonist muscimol and benzodiazepine triazolam. Intraperitoneal administration of 8-OH-DPAT, buspirone, ipsapirone, muscimol and triazolam at circadian time (CT) 8 (CT 12; onset of activity) induced a significant phase advance of wheel-running activity under constant light conditions. However, administration of these drugs at other CT points did not induce phase changes. The administration of trifluoromethylphenylpiperazine (TFMPP), a 5-HT1B receptor agonist, at CT8 produced a small phase advance. The phase advance induced by 8-OH-DPAT was blocked by pretreatment with (-)-pindolol, a 5-HT1A receptor antagonist. In addition, 8-OH-DPAT, buspirone and SM3997 accelerated the rate of re-entrainment to an 8-h phase advance in the light-dark cycle. These observations suggest that 5-HT1A receptors in the brain participate in the regulation of the circadian rhythm of wheel-running activity in hamsters.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1316283     DOI: 10.1016/0014-2999(92)90099-p

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  23 in total

1.  In vivo resetting of the hamster circadian clock by 5-HT7 receptors in the suprachiasmatic nucleus.

Authors:  J C Ehlen; G H Grossman; J D Glass
Journal:  J Neurosci       Date:  2001-07-15       Impact factor: 6.167

2.  The role of Period1 in non-photic resetting of the hamster circadian pacemaker in the suprachiasmatic nucleus.

Authors:  Toshiyuki Hamada; Michael C Antle; Rae Silver
Journal:  Neurosci Lett       Date:  2004-05-20       Impact factor: 3.046

3.  The effects of aging and chronic fluoxetine treatment on circadian rhythms and suprachiasmatic nucleus expression of neuropeptide genes and 5-HT1B receptors.

Authors:  Marilyn J Duncan; James M Hester; Jason A Hopper; Kathleen M Franklin
Journal:  Eur J Neurosci       Date:  2010-05       Impact factor: 3.386

4.  Alcohol usage and abrupt cessation modulate diurnal activity.

Authors:  Stacy Norrell; Cruz Reyes-Vasquez; Keith Burau; Nachum Dafny
Journal:  Brain Res Bull       Date:  2010-07-06       Impact factor: 4.077

5.  Expression of 5-HT7 receptor mRNA in the hamster brain: effect of aging and association with calbindin-D28K expression.

Authors:  Marilyn J Duncan; Kathleen M Franklin
Journal:  Brain Res       Date:  2007-01-20       Impact factor: 3.252

6.  Both neuropeptide Y and serotonin are necessary for entrainment of circadian rhythms in mice by daily treadmill running schedules.

Authors:  E G Marchant; N V Watson; R E Mistlberger
Journal:  J Neurosci       Date:  1997-10-15       Impact factor: 6.167

7.  NAN-190 potentiates the circadian response to light and speeds re-entrainment to advanced light cycles.

Authors:  E J Kessler; J Sprouse; M E Harrington
Journal:  Neuroscience       Date:  2008-05-06       Impact factor: 3.590

8.  Nonphotic entrainment by 5-HT1A/7 receptor agonists accompanied by reduced Per1 and Per2 mRNA levels in the suprachiasmatic nuclei.

Authors:  K Horikawa; S Yokota; K Fuji; M Akiyama; T Moriya; H Okamura; S Shibata
Journal:  J Neurosci       Date:  2000-08-01       Impact factor: 6.167

9.  Acute ethanol impairs photic and nonphotic circadian phase resetting in the Syrian hamster.

Authors:  Christina L Ruby; Rebecca A Prosser; Marc A DePaul; Randy J Roberts; J David Glass
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-12-10       Impact factor: 3.619

Review 10.  Biological rhythms, higher brain function, and behavior: Gaps, opportunities, and challenges.

Authors:  Ruth Benca; Marilyn J Duncan; Ellen Frank; Colleen McClung; Randy J Nelson; Aleksandra Vicentic
Journal:  Brain Res Rev       Date:  2009-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.